Hisani N. Horne, Ph.D.
Affiliations: | 2010 | Pathology | Duke University, Durham, NC |
Area:
Molecular Biology, OncologyGoogle:
"Hisani Horne"Parents
Sign in to add mentor| Jeffrey R. Marks | grad student | 2010 | Duke | |
| (The role of the myelin and lymphocyte protein (MAL) in breast and ovarian cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Horne HN, Oh H, Sherman ME, et al. (2018) E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Scientific Reports. 8: 6574 |
| Ison G, Howie LJ, Amiri-Kordestani L, et al. (2018) FDA Approval Summary: Niraparib for the maintenance treatment of patients with recurrent ovarian cancer in response to platinum-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Oh H, Pfeiffer RM, Falk RT, et al. (2018) Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: the Susan G. Komen Tissue Bank. International Journal of Cancer |
| Balasubramaniam S, Beaver JA, Horton S, et al. (2017) FDA Approval Summary: Rucaparib for the treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Horne HN, Chung CC, Zhang H, et al. (2016) Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. Plos One. 11: e0160316 |
| Oh H, Khodr ZG, Sherman ME, et al. (2016) Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy. Hormones & Cancer |
| Horne HN, Sherman ME, Pfeiffer RM, et al. (2016) Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Research : Bcr. 18: 24 |
| Horne HN, Oh H, Sherman ME, et al. (2016) Abstract 3451: Breast cancer risk factor associations by loss of E-cadherin tumor tissue expression: A pooled analysis of 5,896 cases in 12 studies from the Breast Cancer Association Consortium (BCAC) Cancer Research. 76: 3451-3451 |
| Gierach GL, Patel DA, Pfeiffer RM, et al. (2015) Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities. Cancer Prevention Research (Philadelphia, Pa.) |
| Figueroa JD, Yang H, Garcia-Closas M, et al. (2015) Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients. Breast Cancer Research and Treatment. 150: 457-66 |